This is the authors' abstract. We don't add key points for this paper.
Twelve subjects were tested with D-amphetamine, yohimbine, clonidine, and a placebo on a task with two levels of stimulus and two levels of response complexity. The purpose of this study was to test the hypothesis that noradrenergic drugs affect early stimulus processes. D-amphetamine speeded reaction time (RT), clonidine slowed it, and yohimbine had no effect. D-amphetamine and yohimbine decreased N1 latency and clonidine increased it. D-amphetamine and yohimbine decreased P3 latency and clonidine increased it but, in each case, only when latency estimates were based on single trials, not on averages. D-amphetamine's effect on RT, not P3, as measured by the average, is consistent with previous results. Single trial measures appear more sensitive. Speeding of N1 and single-trial P3 data indicate that noradrenergic drugs affect processing of early (visual) information. D-amphetamine's speeding of single-trial P3 estimates was attributed to its noradrenergic actions. Yohimbine's speeding of P3 without changing RT is consistent with neural net (parallel) simulations but not with a serial model. These findings support the assumption that different neurotransmitters modulate specific cognitive processes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Halliday et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: